(Q35547289)

8 August 2017

1 reference

title

Recent developments in the treatment of bipolar disorders (English)

1 reference

8 August 2017

1

1 reference

8 August 2017

Seetal Dodd

2

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

Expert Opinion on Investigational Drugs

8 August 2017

published in

1 reference

8 August 2017

volume

12

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

1621-1632

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Lithium, anticonvulsants and suicidal behavior in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

The clinical use of gabapentin in bipolar spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Assessment of treatment response in mania: commentary and new findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Targeted psychosocial interventions for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Redefining mood stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Longitudinal outcome in patients with bipolar disorder assessed by life-charting is influenced by DSM-IV personality disorder symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Volumetric brain imaging findings in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Anatomical MRI study of basal ganglia in bipolar disorder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

MRI study of posterior fossa structures and brain ventricles in bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Use of topiramate, a new anti-epileptic as a mood stabilizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Open-label adjunctive topiramate in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Use of topiramate in treatment-resistant bipolar spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

An open label study of gabapentin in the treatment of acute mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Gabapentin augmentation therapy in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Intravenous Fosphenytoin in Acute Mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Oxcarbazepine: clinical experience with hospitalized psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Oxcarbazepine treatment of refractory bipolar disorder: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Olanzapine versus divalproex in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Maintenance efficacy of divalproex in the prevention of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Tiagabine in treatment refractory bipolar disorder: a clinical case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Levetiracetam for acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Levetiracetam in the treatment of rapid cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Atypical antipsychotics and mood stabilization in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

The impact of response to previous mood stabilizer therapy on response to olanzapine versus placebo for acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Olanzapine was more effective than lorazepam at 2 hours but not at 24 hours in bipolar mania with acute agitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Role of risperidone in bipolar II: an open 6-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Quetiapine for refractory mania in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Suicide risk in bipolar patients: the role of co-morbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

A review of continuation and maintenance electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Transcranial magnetic stimulation in mania: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Effects of a branched-chain amino acid drink in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Acceleration and augmentation strategies for treating bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Cognitive-behavioral therapy: applications for the management of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.10.1621

10.1517/13543784.12.10.1621

21 January 2018

Identifiers

DOI

1 reference

8 August 2017

1 reference